 Seth Septer
Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adenomatous Polyposis Coli | 8 | 2022 | 33 | 2.820 |
Why?
| | Adenomatous Polyposis Coli Protein | 2 | 2018 | 20 | 1.120 |
Why?
| | Genetic Counseling | 2 | 2016 | 71 | 1.020 |
Why?
| | Hepatoblastoma | 3 | 2019 | 41 | 0.650 |
Why?
| | Fibromatosis, Aggressive | 2 | 2016 | 17 | 0.620 |
Why?
| | Dentofacial Deformities | 1 | 2018 | 1 | 0.600 |
Why?
| | Osteosclerosis | 1 | 2018 | 2 | 0.600 |
Why?
| | Osteoma | 1 | 2018 | 2 | 0.600 |
Why?
| | Mandibular Neoplasms | 1 | 2018 | 22 | 0.590 |
Why?
| | Intestinal Polyposis | 2 | 2019 | 7 | 0.580 |
Why?
| | Endoscopy, Gastrointestinal | 3 | 2016 | 217 | 0.570 |
Why?
| | Genetic Testing | 3 | 2019 | 428 | 0.570 |
Why?
| | Neoplastic Syndromes, Hereditary | 2 | 2019 | 38 | 0.560 |
Why?
| | Counselors | 1 | 2016 | 12 | 0.540 |
Why?
| | Genes, APC | 2 | 2019 | 13 | 0.530 |
Why?
| | Liver Neoplasms | 2 | 2016 | 633 | 0.440 |
Why?
| | Polyps | 1 | 2013 | 11 | 0.420 |
Why?
| | Chromosomes, Human, Pair 10 | 1 | 2013 | 18 | 0.410 |
Why?
| | Esophageal Diseases | 1 | 2013 | 27 | 0.410 |
Why?
| | Chromosome Deletion | 1 | 2013 | 102 | 0.400 |
Why?
| | Esophagitis | 1 | 2013 | 67 | 0.400 |
Why?
| | Early Detection of Cancer | 1 | 2016 | 369 | 0.380 |
Why?
| | Mutation | 4 | 2018 | 3689 | 0.370 |
Why?
| | Esophagus | 1 | 2013 | 248 | 0.360 |
Why?
| | Barrett Esophagus | 1 | 2013 | 144 | 0.350 |
Why?
| | Genetic Predisposition to Disease | 2 | 2015 | 2264 | 0.320 |
Why?
| | Phosphoproteins | 1 | 2011 | 327 | 0.320 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2011 | 391 | 0.310 |
Why?
| | Biomarkers, Tumor | 1 | 2015 | 1181 | 0.300 |
Why?
| | Liver | 2 | 2018 | 1826 | 0.290 |
Why?
| | Colectomy | 2 | 2016 | 93 | 0.220 |
Why?
| | Child | 13 | 2022 | 20655 | 0.210 |
Why?
| | Radiography, Panoramic | 2 | 2021 | 11 | 0.200 |
Why?
| | Child, Preschool | 6 | 2019 | 10384 | 0.200 |
Why?
| | Infant | 6 | 2016 | 8914 | 0.170 |
Why?
| | Colonoscopy | 3 | 2019 | 234 | 0.150 |
Why?
| | Cromolyn Sodium | 1 | 2018 | 11 | 0.150 |
Why?
| | Polycystic Kidney, Autosomal Recessive | 1 | 2018 | 6 | 0.150 |
Why?
| | Cell Degranulation | 1 | 2018 | 42 | 0.150 |
Why?
| | Colonic Polyps | 1 | 2019 | 87 | 0.150 |
Why?
| | Craniopharyngioma | 1 | 2019 | 82 | 0.150 |
Why?
| | Jaw | 1 | 2018 | 24 | 0.150 |
Why?
| | Pituitary Neoplasms | 1 | 2019 | 184 | 0.140 |
Why?
| | beta Catenin | 1 | 2019 | 219 | 0.140 |
Why?
| | Cell Proliferation | 2 | 2017 | 2344 | 0.140 |
Why?
| | Mast Cells | 1 | 2018 | 142 | 0.140 |
Why?
| | Polycystic Kidney Diseases | 1 | 2017 | 63 | 0.130 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2017 | 182 | 0.130 |
Why?
| | Prophylactic Surgical Procedures | 1 | 2016 | 6 | 0.130 |
Why?
| | Adolescent | 7 | 2019 | 20179 | 0.130 |
Why?
| | Duodenal Neoplasms | 1 | 2016 | 21 | 0.130 |
Why?
| | Chemoprevention | 1 | 2016 | 90 | 0.130 |
Why?
| | Capsule Endoscopy | 1 | 2015 | 18 | 0.120 |
Why?
| | Prevalence | 2 | 2021 | 2547 | 0.120 |
Why?
| | Humans | 17 | 2022 | 128418 | 0.120 |
Why?
| | Microbiota | 1 | 2022 | 719 | 0.120 |
Why?
| | Male | 10 | 2019 | 62858 | 0.120 |
Why?
| | Genetic Diseases, Inborn | 1 | 2014 | 38 | 0.110 |
Why?
| | Lymphoproliferative Disorders | 1 | 2014 | 54 | 0.110 |
Why?
| | Bone Morphogenetic Protein Receptors, Type I | 1 | 2013 | 9 | 0.100 |
Why?
| | Failure to Thrive | 1 | 2013 | 29 | 0.100 |
Why?
| | Pediatrics | 3 | 2019 | 1046 | 0.100 |
Why?
| | STAT3 Transcription Factor | 1 | 2014 | 190 | 0.100 |
Why?
| | Stomach | 1 | 2013 | 109 | 0.100 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2013 | 70 | 0.100 |
Why?
| | Colorectal Neoplasms | 2 | 2019 | 746 | 0.100 |
Why?
| | Female | 10 | 2019 | 68154 | 0.100 |
Why?
| | Thyroid Neoplasms | 1 | 2016 | 309 | 0.100 |
Why?
| | Vomiting | 1 | 2013 | 126 | 0.100 |
Why?
| | Self Report | 1 | 2016 | 801 | 0.100 |
Why?
| | Gastritis | 1 | 2013 | 96 | 0.100 |
Why?
| | Ion Transport | 1 | 2011 | 57 | 0.100 |
Why?
| | Abdominal Pain | 1 | 2013 | 145 | 0.090 |
Why?
| | Treatment Outcome | 3 | 2016 | 10152 | 0.090 |
Why?
| | PTEN Phosphohydrolase | 1 | 2013 | 157 | 0.090 |
Why?
| | Phenotype | 3 | 2019 | 3044 | 0.090 |
Why?
| | Deglutition Disorders | 1 | 2013 | 131 | 0.090 |
Why?
| | Mass Screening | 1 | 2019 | 1147 | 0.090 |
Why?
| | Epithelial Cells | 1 | 2017 | 1032 | 0.090 |
Why?
| | Cell Cycle Proteins | 2 | 2011 | 577 | 0.090 |
Why?
| | Tretinoin | 1 | 2011 | 128 | 0.090 |
Why?
| | Organ Size | 1 | 2011 | 440 | 0.090 |
Why?
| | Autoimmune Diseases | 1 | 2014 | 423 | 0.090 |
Why?
| | Kidney | 1 | 2018 | 1302 | 0.090 |
Why?
| | Collagen | 1 | 2013 | 429 | 0.090 |
Why?
| | Retrospective Studies | 3 | 2019 | 14454 | 0.090 |
Why?
| | Case-Control Studies | 1 | 2018 | 3328 | 0.090 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2011 | 281 | 0.090 |
Why?
| | Bile Acids and Salts | 1 | 2011 | 194 | 0.090 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2011 | 270 | 0.080 |
Why?
| | Optic Neuritis | 1 | 2008 | 40 | 0.070 |
Why?
| | Pneumonia, Bacterial | 1 | 2008 | 109 | 0.070 |
Why?
| | Bronchiolitis | 1 | 2008 | 87 | 0.070 |
Why?
| | Mice, Inbred C57BL | 2 | 2017 | 5272 | 0.060 |
Why?
| | Feeding and Eating Disorders | 1 | 2008 | 144 | 0.060 |
Why?
| | Biopsy | 2 | 2022 | 1081 | 0.060 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1688 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2011 | 1900 | 0.060 |
Why?
| | Apoptosis | 1 | 2011 | 2435 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2018 | 2239 | 0.050 |
Why?
| | Adult | 4 | 2021 | 35300 | 0.050 |
Why?
| | Clinical Competence | 1 | 2008 | 1013 | 0.040 |
Why?
| | Young Adult | 2 | 2013 | 12312 | 0.040 |
Why?
| | Gastrointestinal Neoplasms | 1 | 2019 | 72 | 0.040 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2019 | 119 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2022 | 623 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2019 | 138 | 0.040 |
Why?
| | Point Mutation | 1 | 2019 | 223 | 0.040 |
Why?
| | Animals | 3 | 2018 | 34479 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2018 | 3937 | 0.040 |
Why?
| | Connective Tissue Growth Factor | 1 | 2017 | 24 | 0.040 |
Why?
| | Age Factors | 2 | 2015 | 3103 | 0.030 |
Why?
| | Adenoma | 1 | 2019 | 213 | 0.030 |
Why?
| | Gastroenterology | 1 | 2019 | 174 | 0.030 |
Why?
| | Consensus | 1 | 2019 | 613 | 0.030 |
Why?
| | RNA Interference | 1 | 2017 | 441 | 0.030 |
Why?
| | Electronic Mail | 1 | 2015 | 60 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2022 | 2710 | 0.030 |
Why?
| | Mice | 1 | 2011 | 16602 | 0.030 |
Why?
| | Evidence-Based Medicine | 1 | 2019 | 711 | 0.030 |
Why?
| | STAT5 Transcription Factor | 1 | 2014 | 48 | 0.030 |
Why?
| | STAT1 Transcription Factor | 1 | 2014 | 70 | 0.030 |
Why?
| | Canada | 1 | 2015 | 344 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2019 | 958 | 0.030 |
Why?
| | Health Care Surveys | 1 | 2015 | 555 | 0.030 |
Why?
| | Dyspepsia | 1 | 2013 | 10 | 0.030 |
Why?
| | Needs Assessment | 1 | 2015 | 359 | 0.030 |
Why?
| | Gastric Mucosa | 1 | 2013 | 50 | 0.030 |
Why?
| | Gene Expression | 1 | 2017 | 1456 | 0.020 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2013 | 57 | 0.020 |
Why?
| | Fellowships and Scholarships | 1 | 2015 | 272 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2602 | 0.020 |
Why?
| | Tissue Array Analysis | 1 | 2011 | 57 | 0.020 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2014 | 375 | 0.020 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 2011 | 65 | 0.020 |
Why?
| | Cholangiocarcinoma | 1 | 2011 | 77 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2017 | 2755 | 0.020 |
Why?
| | Gene Silencing | 1 | 2011 | 185 | 0.020 |
Why?
| | Bile Duct Neoplasms | 1 | 2011 | 99 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5039 | 0.020 |
Why?
| | Phosphorylation | 1 | 2014 | 1681 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2013 | 1009 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4001 | 0.020 |
Why?
| | Cell Communication | 1 | 2011 | 298 | 0.020 |
Why?
| | Curriculum | 1 | 2015 | 917 | 0.020 |
Why?
| | Moraxellaceae Infections | 1 | 2008 | 3 | 0.020 |
Why?
| | Cell Survival | 1 | 2011 | 1077 | 0.020 |
Why?
| | Sampling Studies | 1 | 2008 | 96 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2013 | 1935 | 0.020 |
Why?
| | Chronic Disease | 1 | 2013 | 1705 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2011 | 657 | 0.020 |
Why?
| | Internship and Residency | 1 | 2015 | 1048 | 0.020 |
Why?
| | Adrenal Cortex Hormones | 1 | 2008 | 518 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 3184 | 0.010 |
Why?
| | Transcription Factors | 1 | 2011 | 1628 | 0.010 |
Why?
| | United States | 1 | 2015 | 13830 | 0.010 |
Why?
| | Signal Transduction | 1 | 2011 | 4826 | 0.010 |
Why?
| | Anti-Bacterial Agents | 1 | 2008 | 1663 | 0.010 |
Why?
|
|
Septer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|